Track market-moving stories before they get noisy

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD) (“Ziff Davis” or “the Company”) today reported unaudited financial results for the first quarter ended March 31, 2026.

“We remain focused on unlocking value for our shareholders as we look to complete the divestiture of the Connectivity business as well as explore additional value-creating transactions,” said Vivek Shah, CEO of Ziff Davis. “Our first quarter results demonstrate the strength of many of our businesses while we manage through the headwinds challenging other parts of our portfolio.”

FIRST QUARTER 2026 RESULTS

During the first quarter of 2026, the Company entered into a definitive agreement to sell its Connectivity business. The results of the Connectivity business are classified as discontinued operations for all periods presented in this press release. Unless otherwise noted, all amounts, percentages, and any discussion in this press release reflect the results from continuing operations, except for the Statements of Cash Flows and Free cash flow, which are presented on a combined continuing and discontinued operations basis. Furthermore, upon the classification of Connectivity as discontinued operation, the Company determined that Connectivity is no longer a reportable segment. The Company will continue to own and operate the Connectivity business in the ordinary course until the closing of the transaction.

Revenues (1) decreased to $267.6 million compared to $272.8 million for Q1 2025. Operating income decreased to $2.9 million compared to $14.5 million for Q1 2025. Net (loss) income from continuing operations (2) decreased to $(0.8) million compared to $9.8 million for Q1 2025. Net (loss) income per diluted share from continuing operations (2) decreased to $(0.02) compared to $0.23 for Q1 2025. Adjusted EBITDA (3) decreased to $63.4 million compared to $71.4 million for Q1 2025. Adjusted net income (2) (3) decreased to $27.5 million compared to $33.0 million for Q1 2025. Adjusted net income per diluted share (2) (3) (or “Adjusted diluted EPS”) decreased to $0.73 compared to $0.77 for Q1 2025. Net cash provided by operating activities from continuing and discontinued operations increased 45.3% to $30.0 million compared to $20.6 million in Q1 2025. Free cash flow from continuing and discontinued operations (3) increased 36.6% to $(3.2) million compared to $(5.0) million in Q1 2025. Ziff Davis deployed approximately $51.6 million related to share repurchases in Q1 2026. The following table reflects results from continuing operations, except for Net cash provided by operating activities and Free cash flow which are on combined basis of continuing and discontinued operations, for the three months ended March 31, 2026 and 2025, respectively (in millions, except per share amounts).

(Unaudited)

Three months ended March 31,

% Change

2026

2025

Revenues (1)

Technology & Shopping

$71.1

$81.7

(12.9)%

Gaming & Entertainment

$40.8

$38.0

7.2%

Health & Wellness

$85.9

$85.8

0.2%

Cybersecurity & Martech

$69.8

$67.3

3.6%

Total revenues (1)

$267.6

$272.8

(1.9)%

Operating income

$2.9

$14.5

(79.7)%

Operating income margin

1.1%

5.3%

(4.2)%

Net (loss) income from continuing operations (2)

$(0.8)

$9.8

(107.9)%

Net (loss) income per diluted share from continuing operations (2)

$(0.02)

$0.23

(108.7)%

Adjusted EBITDA (3)

$63.4

$71.4

(11.2)%

Adjusted EBITDA margin (3)

23.7%

26.2%

(2.5)%

Adjusted net income (2)(3)

$27.5

$33.0

(16.5)%

Adjusted diluted EPS (2)(3)

$0.73

$0.77

(5.2)%

Net cash provided by operating activities from continuing and discontinued operations

$30.0

$20.6

45.3%

Free cash flow from continuing and discontinued operations (3)

$(3.2)

$(5.0)

36.6%

Notes:

(1)

The revenues associated with each of the reportable segments may have been rounded when presented independently so they foot precisely to Total Revenues.

(2)

GAAP effective tax rates were approximately (80.5)% and 53.2% for the three months ended March 31, 2026 and 2025, respectively. Adjusted effective tax rates were approximately 23.9% and 23.5% for the three months ended March 31, 2026 and 2025, respectively.

(3)

For definitions of non-GAAP financial measures and reconciliations of GAAP to non-GAAP financial measures refer to section “Non-GAAP Financial Measures” further in this release.

ZIFF DAVIS GUIDANCE

As noted in the Company’s Third Quarter 2025 earnings release, Ziff Davis has engaged outside advisors to assist in evaluating value-creating opportunities, including the recently announced sale of its Connectivity business. As this process is ongoing, the Company is deferring its fiscal 2026 guidance.

EARNINGS CONFERENCE CALL AND AUDIO WEBCAST

Ziff Davis will host a live audio webcast and conference call discussing its first quarter 2026 financial results on Friday, May 8, 2026, at 8:30AM ET. The live webcast and call will be accessible by phone by dialing (844) 985-2014 or via www.ziffdavis.com. Following the event, the audio recording and presentation materials will be archived and made available at www.ziffdavis.com.

ABOUT ZIFF DAVIS

Ziff Davis, Inc. (NASDAQ: ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, health and wellness, connectivity, cybersecurity, and martech. For more information, visit www.ziffdavis.com.

“Safe Harbor” Statement Under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including those contained in Vivek Shah’s quote and the “Ziff Davis Guidance” section. These forward-looking statements are based on management’s current expectations or beliefs and are subject to numerous assumptions, risks, and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These factors and uncertainties include, among other items: the Company’s ability to grow advertising, licensing, and subscription revenues, profitability, and cash flows, particularly in light of an uncertain U.S. or worldwide economy, including the possibility of economic downturn or recession; the Company’s ability to make interest and debt payments; the Company’s ability to identify, close, and successfully transition acquisitions or divestitures; the Company’s ability to complete the proposed divestiture of its Connectivity business on anticipated terms and timing, or at all; the Company’s ability to realize the anticipated benefits from the divestiture of the Connectivity business; customer growth and retention; the Company’s ability to create compelling content; our reliance on third-party platforms; the threat of content piracy and developments related to artificial intelligence; increased competition and rapid technological changes; variability of the Company’s revenue based on changing conditions in particular industries and the economy generally; protection of the Company’s proprietary technology; the risk of alleged infringement by the Company of intellectual property of others; the risk of losing critical third-party vendors or key personnel; the risks associated with fraudulent activity, system failure, or a security breach; risks related to our ability to adhere to our internal controls and procedures; the risk of adverse changes in the U.S. or international regulatory environments, including but not limited to the imposition or increase of taxes or regulatory-related fees; the risks related to supply chain disruptions, increased tariffs and trade protection measures, inflationary conditions, and rising interest rates; the risk of liability for legal and other claims; our ability to consummate a sale of one or more of our business lines pursuant to our announced review of potential value-creating opportunities; and the numerous other factors set forth in the Company’ filings with the Securities and Exchange Commission (“SEC”). For a more detailed description of the risk factors and uncertainties affecting the Company, refer to our most recent Annual Report on Form 10-K and the other reports filed by the Company from time-to-time with the SEC, each of which is available at www.sec.gov. The forward-looking statements provided in this press release, including those contained in Vivek Shah’s quote and the “Ziff Davis Guidance” section are based on limited information available to the Company at this time, which is subject to change. Although management’s expectations may change after the date of this press release, the Company undertakes no obligation to revise or update these statements.

  ZIFF DAVIS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED, IN THOUSANDS)

  March 31, 2026

December 31, 2025

ASSETS

Cash and cash equivalents

$

519,718

$

573,777

Accounts receivable, net of allowances of $6,633 and $8,141, respectively

397,456

623,441

Prepaid expenses and other current assets

83,101

81,964

Current assets - held for sale

435,223

91,217

Total current assets

1,435,498

1,370,399

Long-term investments

100,075

93,228

Property and equipment, net of accumulated depreciation of $399,945 and $382,187, respectively

166,924

162,130

Intangible assets, net

314,134

338,178

Goodwill

1,343,817

1,346,964

Deferred income taxes

5,419

5,107

Other assets

28,418

24,523

Noncurrent assets - held for sale

—

322,777

TOTAL ASSETS

$

3,394,285

$

3,663,306

LIABILITIES AND STOCKHOLDERS’ EQUITY

Accounts payable and accrued expenses

$

450,266

$

696,918

Income taxes payable, current

2,706

7,345

Deferred revenue, current

132,048

129,700

Current portion of long-term debt

148,810

148,685

Other current liabilities

15,521

16,089

Current liabilities - held for sale

114,365

76,216

Total current liabilities

863,716

1,074,953

Long-term debt

718,257

717,815

Deferred revenue, noncurrent

6,105

6,518

Liability for uncertain tax positions

20,150

19,733

Deferred income taxes

30,157

41,116

Other noncurrent liabilities

34,392

33,055

Noncurrent liabilities - held for sale

—

16,541

TOTAL LIABILITIES

1,672,777

1,909,731

Common stock

374

384

Additional paid-in capital

454,325

472,723

Retained earnings

1,332,193

1,337,542

Accumulated other comprehensive loss

(65,384

)

(57,074

)

TOTAL STOCKHOLDERS’ EQUITY

1,721,508

1,753,575

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

3,394,285

$

3,663,306

  ZIFF DAVIS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED, IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

  Three months ended March 31,

2026

2025

Total revenues

$

267,641

$

272,816

Operating costs and expenses:

Direct costs

44,317

40,401

Sales and marketing

115,233

112,411

Research, development, and engineering

13,637

13,920

General, administrative, and other related costs

46,644

43,163

Depreciation and amortization

44,878

48,452

Total operating costs and expenses

264,709

258,347

Operating income

2,932

14,469

Interest expense, net

(6,896

)

(6,194

)

Other income (loss), net

688

(1,475

)

(Loss) income from continuing operations before income tax expense and income from equity method investment

(3,276

)

6,800

Income tax expense

(2,637

)

(3,618

)

Income from equity method investment, net of tax

5,138

6,630

Net (loss) income from continuing operations

(775

)

9,812

Net income from discontinued operations, net of tax

23,036

14,427

Net income

$

22,261

$

24,239

Net (loss) income per common share from continuing operations:

Basic

$

(0.02

)

$

0.23

Diluted

$

(0.02

)

$

0.23

Net income per common share from discontinued operations:

Basic

$

0.61

$

0.34

Diluted

$

0.61

$

0.34

Net income per common share:

Basic

$

0.59

$

0.57

Diluted

$

0.59

$

0.57

Weighted average shares outstanding:

Basic

37,597,190

42,558,090

Diluted

37,597,190

42,768,678

  ZIFF DAVIS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED, IN THOUSANDS)

  Three months ended March 31,

2026

2025

Cash flows from operating activities:

Net income

$

22,261

$

24,239

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

49,783

55,832

Non-cash operating lease costs

2,037

2,034

Share-based compensation

10,913

9,752

Provision for credit losses on accounts receivable

1,129

160

Deferred income taxes, net

(12,323

)

548

Changes in fair value of contingent consideration

124

(1,803

)

Income from equity method investments, net of tax

(5,138

)

(6,630

)

Other

1,129

912

Decrease (increase) in:

Accounts receivable

195,297

143,721

Prepaid expenses and other current assets

(3,826

)

(17,709

)

Other assets

(1,813

)

7,252

Increase (decrease) in:

Accounts payable

(247,695

)

(210,857

)

Deferred revenue

22,894

18,493

Accrued liabilities and other current liabilities

(4,819

)

(5,331

)

Net cash provided by operating activities

29,953

20,613

Cash flows from investing activities:

Purchases of property and equipment

(33,127

)

(25,619

)

Acquisitions, net of cash received

—

(39,198

)

Other

(80

)

(12

)

Net cash used in investing activities

(33,207

)

(64,829

)

Cash flows from financing activities:

Repurchase of common stock

(51,594

)

(34,900

)

Other

(1,901

)

(106

)

Net cash used in financing activities

(53,495

)

(35,006

)

Effect of exchange rate changes on cash and cash equivalents

(4,446

)

4,349

Net change in cash and cash equivalents

(61,195

)

(74,873

)

Cash and cash equivalents at beginning of period

607,011

505,880

Cash and cash equivalents at beginning of period associated with discontinued operations

33,234

18,380

Cash and cash equivalents at beginning of period associated with continuing operations

573,777

487,500

Cash and cash equivalents at end of period

545,816

431,007

Cash and cash equivalents at end of period associated with discontinued operations

26,098

19,090

Cash and cash equivalents at end of period associated with continuing operations

$

519,718

$

411,917

  Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with U.S. generally accepted accounting principles (“GAAP”), we use the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net income (loss), Adjusted net income (loss) per diluted share, Free cash flow from continuing and discontinued operations, and Adjusted effective tax rate (collectively the “non-GAAP financial measures”). The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

We use these non-GAAP financial measures for financial and operational decision making and as means to evaluate period-to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain items that may not be indicative of our recurring core business operating results or, in certain cases, may be non-cash in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance and liquidity. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, (2) certain measures are used to determine the amount of annual incentive compensation paid to our named executive officers, and (3) they are used by the analyst community to help them analyze the health of our business.

These non-GAAP financial measures are not measures presented in accordance with GAAP, and our use of these terms may vary from that of other companies, limiting their usefulness for comparison purposes. These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. These non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with the Company’s results of operations determined in accordance with GAAP.

Non-GAAP financial measures exclude the certain items listed below. We believe that excluding these items from the non-GAAP measures facilitates comparisons to historical operating results and comparisons to peers, many of which exclude similar items. We believe that non-GAAP financial measures provide meaningful supplemental information regarding operational performance. We further believe these measures are useful to investors in that they allow for greater transparency of certain line items in the Company’s financial statements.

Adjusted EBITDA is defined as Net income (loss) from continuing operations with adjustments to reflect the addition or elimination of certain items including, but not limited to:

Interest expense, net. Interest expense is generated primarily from interest due on outstanding debt, partially offset by interest income generated from the interest earned on cash, cash equivalents, and investments; (Gain) loss on debt extinguishment, net. This is a non-cash expense that relates to extinguishments of long-term debt obligations. We believe this (gain) loss does not represent recurring core business operating results of the Company; (Gain) loss on sale of businesses. This gain or loss relates to the sales of businesses and does not represent recurring core business operating results of the Company; (Gain) loss on investments, net. This item includes realized gains and losses, unrealized gains and losses, and impairment charges on debt and equity investments. The amount of gain or loss depends on the share price for investments with readily determinable fair value and on observable price changes for investments without a readily determinable fair value, and does not represent core business operating results of the Company; Provision for credit losses on investments. This is a non-cash expense that includes changes in the provision for credit losses on investments of the Company in debt and equity instruments and does not represent recurring core business operating results of the Company; Other (income) loss, net. This income or expense relates to other non-operating items and does not represent recurring core business operating results of the Company; Income tax (benefit) expense. This benefit or expense depends on the pre-tax loss or income of the Company, statutory tax rates, tax regulations, and different tax rates in various jurisdictions in which the Company operates and which the Company does not have the control over; (Income) loss from equity method investment, net of tax. This is a non-cash income or expense as it relates primarily to our investment in OCV Fund I, LP (the “OCV Fund”). We believe that gain or loss resulting from our equity method investment does not represent core business operating results of the Company; Depreciation and amortization. This is a non-cash expense at it relates to use and associated reduction in value of certain assets including equipment, fixtures, and certain capitalized internal-use software and website development costs, and identifiable definite-lived intangible assets of the acquired businesses; Share-based compensation. This is a non-cash expense as it relates to awards granted under the various share-based incentive plans of the Company. We view the economic cost of share-based awards to be the dilution to our share base; Transaction, integration, and other charges. This includes expenses associated with the acquisition or disposal of certain businesses, lease agreement terminations, retention bonuses, and other transaction-specific items, as well as certain other items, such as severance, adjustments to contingent consideration, third-party debt modification costs, litigation costs from discrete, complex, or unusual proceedings, and legal settlements. These expenses do not represent core business operating results of the Company; Lease asset impairments and other charges. These expenses are incurred in connection with impaired right-of-use (“ROU”) assets of the Company. Associated expenses are comprised of insurance, utility, and other charges related to assets that are no longer in use, and partially offset by the sublease income earned. These expenses do not represent core business operating results of the Company; and Goodwill impairment. This is a non-cash expense that is recorded when the carrying value of the reporting unit exceeds its fair value and does not represent core business operating results of the Company. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Total Revenues.

Adjusted net income (loss) is defined as Net income (loss) from continuing operations with adjustments to reflect the addition or elimination of certain statement of operations items including, but not limited to:

Interest, net. This reflects the difference between the imputed and coupon interest expense associated with the 4.625% Senior Notes and a charge that the Company determined to be penalty interest associated with the 1.75% Convertible Notes, offset in part by a certain interest income earned by the Company. These net expenses do not represent core business operating results of the Company; (Gain) loss on debt extinguishment, net. This is a non-cash expense that relates to extinguishments of long-term debt obligations. We believe this gain or loss does not represent recurring core business operating results of the Company; (Gain) loss on sale of businesses. This gain or loss relates to the sales of businesses and does not represent recurring core business operating results of the Company; (Gain) loss on investments, net. This item includes realized gains and losses, unrealized gains and losses, and impairment charges on debt and equity investments. The amount of gain or loss depends on the share price for investments with readily determinable fair value and on observable price changes for investments without a readily determinable fair value, and does not represent core business operating results of the Company; Provision for credit losses on investments. This is a non-cash expense that includes changes in the provision for credit losses on investments of the Company in debt and equity instruments and does not represent recurring core business operating results of the Company; (Income) loss from equity method investment, net of tax. This is a non-cash income or expense as it relates primarily to our investment in the OCV Fund. We believe that gains or losses resulting from our equity method investment do not represent core business operating results of the Company; Amortization. Includes the amortization of patents and intangible assets that we acquired. This is a non-cash expense as it primarily relates to identifiable definite-lived intangible assets of the acquired businesses. We believe that acquired intangible assets represent cost incurred by the acquiree to build value prior to the acquisition and the amortization of this cost does not represent core business operating results of the Company; Share-based compensation. This is a non-cash expense as it relates to awards granted under the various share-based incentive plans of the Company. We view the economic cost of share-based awards to be the dilution to our share base; Transaction, integration, and other charges. This includes expenses associated with the acquisition or disposal of certain businesses, lease agreement terminations, retention bonuses, and other transaction-specific items, as well as certain other items, such as severance, adjustments to contingent consideration, third-party debt modification costs, litigation costs from discrete, complex, or unusual proceedings, and legal settlements. These expenses do not represent core business operating results of the Company; Lease asset impairments and other charges. These expenses are incurred in connection with impaired ROU assets of the Company. Associated expenses are comprised of insurance, utility, and other charges related to assets that are no longer in use, and partially offset by the sublease income earned. These expenses do not represent core business operating results of the Company; and Goodwill impairment. This is a non-cash expense that is recorded when the carrying value of the reporting unit exceeds its fair value and does not represent core business operating results of the Company. Adjusted net income (loss) per diluted share is calculated by dividing Adjusted net income (loss) from continuing operations by the diluted weighted average shares of common stock outstanding excluding the effect of convertible debt dilution.

Free cash flow from continuing and discontinued operations is defined as Net cash provided by operating activities, which includes both continuing and discontinued operations, less purchases of property and equipment, plus changes in contingent consideration (if any).

Adjusted effective tax rate is calculated based upon the GAAP effective tax rate with adjustments for the tax applicable to non-GAAP adjustments to Net income (loss) from continuing operations, generally based upon the effective marginal tax rate of each adjustment.

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS)

  The following table sets forth a reconciliation of Net (loss) income from continuing operations to Adjusted EBITDA:

  Three months ended March 31,

2026

2025

Net (loss) income from continuing operations

$

(775

)

$

9,812

Interest expense, net

6,896

6,194

Other (income) loss, net

(688

)

1,475

Income tax expense

2,637

3,618

Income from equity method investment, net of tax

(5,138

)

(6,630

)

Depreciation and amortization

44,878

48,452

Share-based compensation

8,548

9,082

Transaction, integration, and other charges

6,632

(641

)

Lease asset impairments and other charges

367

20

Adjusted EBITDA

$

63,357

$

71,382

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS)

  The following tables set forth Revenues and a reconciliation of Operating (loss) income to Adjusted EBITDA by segment:

  Three months ended March 31, 2026

Technology &
Shopping

Gaming &
Entertainment

Health &
Wellness

Cybersecurity
& Martech

Corporate

Total

Revenues

$

71,159

$

40,764

$

85,950

$

69,768

$

—

$

267,641

Operating (loss) income

$

(6,458

)

$

7,884

$

8,624

$

13,697

$

(20,815

)

$

2,932

Depreciation and amortization

20,637

3,168

13,846

7,076

151

44,878

Share-based compensation

1,344

405

1,466

1,007

4,326

8,548

Transaction, integration, and other charges

1,430

776

670

2

3,754

6,632

Lease asset impairments and other charges

—

431

(108

)

44

—

367

Adjusted EBITDA

$

16,953

$

12,664

$

24,498

$

21,826

$

(12,584

)

$

63,357

  Three months ended March 31, 2025

Technology &
Shopping

Gaming &
Entertainment

Health &
Wellness

Cybersecurity
& Martech

Corporate (1)

Total

Revenues

$

81,690

$

38,026

$

85,786

$

67,314

$

—

$

272,816

Operating (loss) income

$

(3,963

)

$

8,774

$

16,962

$

11,323

$

(18,627

)

$

14,469

Depreciation and amortization

22,405

2,618

12,928

10,387

114

48,452

Share-based compensation

1,153

329

1,363

967

5,270

9,082

Transaction, integration, and other charges

1,652

338

(1,812

)

(754

)

(65

)

(641

)

Lease asset impairments and other charges

(241

)

87

(86

)

255

5

20

Adjusted EBITDA

$

21,006

$

12,146

$

29,355

$

22,178

$

(13,303

)

$

71,382

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

  The following tables set forth a reconciliation of Net (loss) income from continuing operations to Adjusted net income with adjustments presented on after-tax basis:

  Three months ended March 31,

2026

Per diluted
share (1)

2025

Per diluted
share (1)

Net (loss) income from continuing operations

$

(775

)

$

(0.02

)

$

9,812

$

0.23

Interest, net

95

—

61

—

Income from equity method investment, net

(5,138

)

(0.14

)

(6,630

)

(0.16

)

Amortization

19,563

0.52

21,107

0.49

Share-based compensation

7,590

0.20

9,226

0.22

Transaction, integration, and other charges

5,905

0.16

(607

)

(0.01

)

Lease asset impairment and other charges

306

0.01

27

—

Adjusted net income

$

27,546

$

0.73

$

32,996

$

0.77

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS)

  The following are the adjustments to certain statement of operations items used to derive Adjusted net income, which we believe provide useful information about our operating results and enhance the overall understanding of past financial performance and future prospects of the Company.

  Three months ended March 31, 2026

GAAP amount

Adjustments

Adjusted
non-GAAP
amount

Interest, net

(Income) loss
from equity
method
investments, net

Amortization

Share-based
compensation

Transaction,
integration, and
other charges

Lease asset
impairments and
other charges

Direct costs

$

(44,317

)

$

—

$

—

$

—

$

52

$

89

$

—

$

(44,176

)

Sales and marketing

$

(115,233

)

—

—

—

989

1,474

—

$

(112,770

)

Research, development, and engineering

$

(13,637

)

—

—

—

678

831

—

$

(12,128

)

General, administrative, and other related costs

$

(46,644

)

—

—

—

6,829

4,238

367

$

(35,210

)

Depreciation and amortization

$

(44,878

)

—

—

23,550

—

—

—

$

(21,328

)

Interest expense, net

$

(6,896

)

126

—

—

—

—

—

$

(6,770

)

Other income, net

$

688

—

—

—

—

234

—

$

922

Income tax benefit (expense) (1)

$

(2,637

)

(31

)

—

(3,987

)

(958

)

(961

)

(61

)

$

(8,635

)

Income from equity method investment, net of tax

$

5,138

—

(5,138

)

—

—

—

—

$

—

Total non-GAAP adjustments

$

95

$

(5,138

)

$

19,563

$

7,590

$

5,905

$

306

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS)

  Three months ended March 31, 2025

GAAP amount

Adjustments

Adjusted
non-GAAP
amount

Interest, net

(Income) loss
from equity
method
investments, net

Amortization

Share-based
compensation

Transaction,
integration, and
other charges

Lease asset
impairments and
other charges

Direct costs

$

(40,401

)

$

—

$

—

$

—

$

52

$

60

$

—

$

(40,289

)

Sales and marketing

$

(112,411

)

—

—

—

798

903

—

$

(110,710

)

Research, development, and engineering

$

(13,920

)

—

—

—

681

(65

)

—

$

(13,304

)

General, administrative, and other related costs

$

(43,163

)

—

—

—

7,551

(1,539

)

20

$

(37,131

)

Depreciation and amortization

$

(48,452

)

—

—

27,777

—

—

—

$

(20,675

)

Interest expense, net

$

(6,194

)

81

—

—

—

—

—

$

(6,113

)

Income tax expense (1)

$

(3,618

)

(20

)

—

(6,670

)

144

34

7

$

(10,123

)

Income from equity method investment, net of tax

$

6,630

—

(6,630

)

—

—

—

—

$

—

Total non-GAAP adjustments

$

61

$

(6,630

)

$

21,107

$

9,226

$

(607

)

$

27

  ZIFF DAVIS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(UNAUDITED, IN THOUSANDS)

  The following tables set forth a reconciliation of Net cash provided by operating activities from continuing and discontinued operations to Free cash flow from continuing and discontinued operations:

  2026

Q1

Q2

Q3

Q4

Full Year

Net cash provided by operating activities from continuing and discontinued operations

$

29,953

$

—

$

—

$

—

$

29,953

Less: Purchases of property and equipment

(33,127

)

—

—

—

(33,127

)

Free cash flow from continuing and discontinued operations

$

(3,174

)

$

—

$

—

$

—

$

(3,174

)

2025

Q1

Q2

Q3

Q4

Full Year

Net cash provided by operating activities from continuing and discontinued operations

$

20,613

$

57,074

$

138,299

$

191,082

$

407,068

Less: Purchases of property and equipment

(25,619

)

(30,133

)

(30,136

)

(33,310

)

(119,198

)

Free cash flow from continuing and discontinued operations

$

(5,006

)

$

26,941

$

108,163

$

157,772

$

287,870

More News From Ziff Davis, Inc.

Ziff Davis, Inc. (ZD) Q1 2026 Earnings Call Transcript

On May 15, 2026, Monimus Capital Management disclosed a new position in Ziff Davis (ZD +1.07%), acquiring 241,918 shares in a trade estimated at $8.90 million based on quarterly average pricing.

What happenedAccording to an SEC filing dated May 15, 2026, Monimus Capital Management established a new position in Ziff Davis, buying 241,918 shares. The estimated value of the trade was $8.90 million, calculated using the mean unadjusted closing price within the first quarter. The quarter-end value of the stake was $10.15 million, a net change reflecting both the portfolio addition and price movement.

What else to knowTop holdings after the filing:NASDAQ: TRIP: $26.72 million (7.4% of AUM)NASDAQ: BKNG: $18.92 million (5.2% of AUM)NASDAQ: AMZN: $15.02 million (4.2% of AUM)NYSE: RSKD: $14.47 million (4.0% of AUM)NYSE: MSGS: $13.43 million (3.7% of AUM)As of May 14, 2026, shares of Ziff Davis were priced at $40.62, up 21.4% over the past year and underperforming the S&P 500 by 5.87 percentage points.Company overviewMetricValueRevenue (TTM)$1.45 billionNet Income (TTM)$47.35 millionPrice (as of market close 2026-05-14)$40.62One-Year Price Change21.43%Company snapshotZiff Davis provides digital media properties (such as IGN, PCMag, Mashable, RetailMeNot, and Everyday Health) and cloud-based subscription services in cybersecurity and marketing technology.The company generates revenue primarily through advertising, digital subscriptions, and SaaS-based cybersecurity and martech offerings across a diversified portfolio.It serves consumers, businesses, and advertisers globally, targeting technology, entertainment, health, and e-commerce verticals.Ziff Davis, Inc. operates as a diversified digital media and internet services company with a global footprint. Its strategy leverages a broad portfolio of well-known web properties and SaaS solutions to capture revenue from both consumer and enterprise markets.

What this transaction means for investorsThis purchase ultimately seems like a bet that Ziff Davis is worth more broken apart than bundled together. Management is actively exploring “value-creating transactions” and, in the first quarter, agreed to sell its Connectivity business, which could sharpen the company’s focus on higher-margin digital media, cybersecurity, and subscription businesses.

The latest quarter showed why that thesis is complicated but still interesting. Revenue slipped 1.9% year over year to $267.6 million, while operating income fell nearly 80% to $2.9 million. Still, some segments held up well. Gaming and Entertainment revenue climbed 7.2%, while Cybersecurity and Martech revenue rose 3.6%.

The company also remained aggressive on capital returns, spending roughly $51.6 million on share repurchases during the quarter. Ziff Davis ended March with about $520 million in continuing-operations cash and cash equivalents.

Going forward, the key question is whether Ziff Davis can unlock value through asset sales while stabilizing its slower-growth media properties. If management pulls that off, the current valuation could look far less demanding than the market assumes today.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Booking Holdings, and Tripadvisor. The Motley Fool has a disclosure policy.

-

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in one investor conference in June.

Details of the conference are as follows:

2026 Evercore TMT Global Conference
Location: Omni San Francisco Hotel, San Francisco, CA
Date and time: June 2, 2026
Webcast: No formal presentation

About Ziff Davis

Ziff Davis (NASDAQ: ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, health and wellness, connectivity, cybersecurity, and martech. For more information, visit www.ziffdavis.com.

More News From Ziff Davis, Inc.

Back to Newsroom

What happenedPale Fire Capital SE reported buying 1,573,414 shares of Ziff Davis (ZD +1.07%) in its quarterly disclosure to the U.S. Securities and Exchange Commission (SEC filing) dated May 14, 2026. The estimated value of the trade is $57.86 million, calculated using the average closing price for the first quarter of 2026. The quarter-end value of the position rose by $74.26 million, a figure that incorporates both trading activity and price movement.

What else to knowThe fund increased its Ziff Davis holdings, which now comprise 10.26% of its 13F assets under management.

Top five holdings after the filing:

NYSEMKT: BTG: $315.92 million (27.8% of AUM)NYSE: DOLE: $134.72 million (11.8% of AUM)NASDAQ: GRPN: $121.15 million (10.6% of AUM)As of May 13, 2026, Ziff Davis shares were priced at $40.53, up 19.2% over the past year, underperforming the S&P 500 by 7.22 percentage points.

Company overviewMetricValueRevenue (TTM)$1.45 billionNet income (TTM)$36.77 millionPrice (as of market close May 13, 2026)$40.53One-year price change19.24%Company snapshotZiff Davis, Inc. is a diversified digital media and technology company with a portfolio spanning content, commerce, and cloud-based services. The company leverages its well-known brands and scalable technology platforms to drive audience engagement and recurring revenue streams.

The company operates digital media brands such as IGN, PCMag, RetailMeNot, Mashable, and Everyday Health, as well as cloud-based cybersecurity and martech subscription services. It generates revenue through advertising, affiliate marketing, subscription fees, and SaaS offerings across its digital media and cybersecurity segments.

Ziff Davis, Inc. serves a global audience of consumers, businesses, and healthcare professionals seeking technology, shopping, entertainment, and health information. Its strategic focus on digital media and cybersecurity positions it as a leader in providing information and solutions to both consumers and businesses worldwide.

What this transaction means for investorsZiff Davis operates a digital media and internet portfolio in which stronger business segments are required to offset ongoing challenges in technology and shopping. The company owns brands spanning gaming and entertainment, health and wellness, cybersecurity, martech, and consumer technology, which provide revenue streams beyond advertising.

The company’s first-quarter results highlight the need for further validation of this business mix. Revenue from continuing operations declined 1.9% year over year to $267.6 million, and adjusted EBITDA decreased to $63.4 million from $71.4 million. These figures indicate ongoing pressure in certain segments, but Ziff Davis also generates revenue through health, gaming, cybersecurity, and martech, which diversifies its monetization beyond advertising.

For investors, the portfolio reset is significant because Ziff Davis must now demonstrate that its remaining businesses can generate earnings without its Connectivity division. While share repurchases may support per-share value, consistent cash generation from the ongoing portfolio is more critical. The clearest indicator of progress would be stabilization in technology and shopping, along with sustained contributions from health, gaming, cybersecurity, and martech

-

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), will host a conference call and webcast on March 20, 2026, at 9:00 AM Eastern Daylight Time to discuss its year end and fourth quarter 2025 results, recent operational developments, and key strategic priorities. A replay of the webcast will be available on Westwater’s website following the event.

Conference Call and Webcast Details

Time and Date: March 20, 2026 at 9:00 AM EDT
Webcast Link: https://events.q4inc.com/attendee/751008790

Investors interested in submitting questions for management may do so in advance of the call by emailing [email protected].

About Westwater Resources, Inc.

Westwater Resources, Inc. (NYSE American: WWR) is a critical minerals and energy technology company advancing a vertically integrated, mine-to-market platform for battery-grade natural graphite in the United States. The Company’s platform is anchored by the Coosa Graphite Deposit in Alabama, the largest natural flake graphite deposit in the contiguous United States, and the Kellyton Graphite Plant, a processing facility designed to produce coated spherical purified graphite (CSPG), a key material used in lithium-ion battery anodes. For more information, visit WestwaterResources.com.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words and phrases such as “results,” “developments,” “key strategic priorities,” and other similar words. Forward looking statements include, among other things, statements concerning: operational developments including the construction of the Kellyton Graphite Plant, the development of the Coosa Graphite Deposit, and the costs, schedules, production and economic projections associated with both of them, and strategic priorities including progress on financing for the Kellyton Graphite Plant. The Company cautions that there are factors that could cause actual results to differ materially from the forward-looking information that has been provided.

The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of the Company; accordingly, there can be no assurance that such suggested results will be realized. Those uncertainties and other factors are discussed in Westwater’s Annual Report on Form 10-K for the year ended December 31, 2024, and the year ended December 31, 2025, which will be available before the date of the call, and subsequent securities filings, and they could cause actual results to differ materially from management expectations.

More News From Westwater Resources, Inc.

Back to Newsroom

Westwater Resources, Inc. (WWR) Q4 2025 Earnings Call Transcript

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and critical minerals company focused on developing battery-grade natural graphite (“Westwater,” “Westwater Resources,” or the “Company”), today announced a commercial update. On March 31, 2026, SK On Co., Ltd. notified the Company of its decision to terminate the Products Procurement Agreement (“Agreement”) originally executed in February 2024. The Agreement represented the purchase of a po.

-

Company Continues Advancing Coosa Permitting Efforts, Customer Qualification Activities, and Kellyton Construction

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), today announced business and financial results for the first quarter ended March 31, 2026.

“During the first quarter, we continued to advance our vertically integrated, mine-to-market graphite platform in Alabama,” said Frank Bakker, President and Chief Executive Officer of Westwater Resources. “Our focus remains on execution across Coosa permitting, qualification activities, and measured construction progress at Kellyton, while actively pursuing financing initiatives to support completion of Phase I. We are prioritizing non-dilutive and lower-cost capital where available, including potential government funding programs, as we work to build a domestic supply chain for battery-grade graphite.”

First Quarter 2026 Highlights

Coosa Graphite Deposit

Continued advancement of permitting activities for the Coosa Graphite Deposit (“Coosa”) Received “covered project” designation under the FAST-41 Federal Permitting Program during the quarter Filed application for a National Pollutant Discharge Elimination System (“NPDES”) permit with the Alabama Department of Environmental Management (“ADEM”), a key environmental permit associated with future mine development activities at Coosa Continued geotechnical analyses, hydrologic monitoring, and permitting-related technical work Continued preparation of the U.S. Army Corps of Engineers Individual Permit application and Alabama air permitting activities Company believes the project is substantially past fieldwork risk related to cultural, wetland, and stream identification activities Kellyton Graphite Plant

Continued construction and operational readiness activities at the Kellyton Graphite Plant (“Kellyton”) Qualification line continued producing CSPG samples representative of future commercial production, positioning Westwater among the most advanced domestic graphite developers in the United States Continued operation of the Company’s R&D Lab to support product optimization, customer qualification efforts, and in-house quality control testing Approximately $130 million has been invested into Kellyton Phase I since inception of the project Company continues to maintain its estimated Phase I capital cost of approximately $245 million, including approximately $19 million of untouched contingency and potential cost escalations Initial production remains expected within approximately 12 months of securing the remaining project financing Customer Engagement & Commercial Activities

Continued customer qualification and commercial engagement activities through the Company’s operational qualification line Ongoing discussions with prospective customers, including global lithium-ion battery manufacturers and OEMs Continued engagement with prospective customers evaluating U.S.-based sources of battery-grade graphite amid evolving industrial policy and critical mineral supply chain priorities As previously announced, SK On Co., Ltd. elected to terminate the Products Procurement Agreement originally executed in February 2024 “Westwater’s integrated platform is aligned with both market demand and the federal government’s focus on domestic critical mineral supply chains,” added Mr. Bakker. “Our ability to produce CSPG samples today through the Kellyton qualification line, while advancing Coosa as a future domestic feedstock source, provides a clear point of differentiation as customers evaluate secure U.S.-based supply alternatives.”

Financing & Liquidity

Cash balance of approximately $41.5 million as of March 31, 2026 Raised approximately $1.2 million of net proceeds through the ATM Sales Agreement during the quarter Approximately $70.6 million remained available under the ATM Sales Agreement as of March 31, 2026 Continued engagement on a variety of government funding opportunities, as well as on other capital markets opportunities with a preference for non-dilutive and lower-cost sources of capital Company continues to maintain a measured approach to capital deployment while evaluating financing alternatives First Quarter 2026 Financial Results

Net loss for the first quarter of 2026 was approximately $4.7 million, or $0.04 per share, compared to a net loss of approximately $2.7 million, or $0.04 per share, for the same period in 2025.

The increase in net loss was primarily related to increased permitting activities at Coosa, higher stock-based compensation expense, and increased product development and qualification activities.

Conference Call and Webcast

Westwater will host a conference call and webcast on May 13, 2026 at 11:00 AM Eastern Time to discuss its first quarter 2026 results and to provide a corporate update.

Webcast Link:
https://events.q4inc.com/attendee/265765325

Investors interested in submitting questions for management may do so in advance of the call by emailing [email protected]. A replay of the webcast will be available on the Company’s website following the event.

About Westwater Resources, Inc.

Westwater Resources, Inc. (NYSE American: WWR) is a critical minerals and energy technology company advancing a vertically integrated, mine-to-market platform for battery-grade natural graphite in the United States. The Company’s platform is anchored by the Coosa Graphite Deposit in Alabama, the largest natural flake graphite deposit in the contiguous United States, and the Kellyton Graphite Plant, a processing facility designed to produce coated spherical purified graphite (CSPG), a key material used in lithium-ion battery anodes. For more information, visit WestwaterResources.com.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words and phrases such as “continues advancing,” “results,” “execution,” “measured,” “actively pursuing,” “prioritizing,” “potential,” “future,” “believes,” “substantially,” “risk,” “most advanced,” “optimization,” “approximately,” “expected,” “prospective,” “evolving,” “priorities,” “aligned,” “clear point of differentiation,” “preference,” “measured,” “alternatives,” “increase,” “primarily,” and other similar words. Forward looking statements include, among other things, statements concerning: operational developments including the construction of the Kellyton Graphite Plant, the development of the Coosa Graphite Deposit, and the costs, schedules, production and economic projections associated with both of them, and strategic priorities including progress on financing for the Kellyton Graphite Plant. The Company cautions that there are factors that could cause actual results to differ materially from the forward-looking information that has been provided.

The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of the Company; accordingly, there can be no assurance that such suggested results will be realized. Those uncertainties and other factors are discussed in Westwater’s Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent securities filings, and they could cause actual results to differ materially from management expectations.

More News From Westwater Resources, Inc.

Back to Newsroom

Key Takeaways XRAY advances growth via digital workflows and higher R&D spend targeting implants and orthodontics.New dealer partnerships and restructuring aim to boost U.S. reach and generate $120M in annual savings.Revenues face pressure from weak demand, tariffs, and declining implant and aligner volumes. DENTSPLY SIRONA (XRAY - Free Report) is well positioned for growth due to its new digital-implant workflow and continued focus on research and development. However, forex headwinds and demand softness in Europe remain a concern.

Shares of this Zacks Rank #3 (Hold) company have gained 1.5% year to date against the industry's 4.5% decline. The S&P 500 Index fell 7.7% in the same time frame.

XRAY, with a market capitalization of $2.24 billion, is a global leader in the design, development, manufacturing and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. It anticipates earnings to improve 5.9% over the next five years.

Image Source: Zacks Investment Research

Factors Favoring XRAY’s GrowthStrategic Reinvestment in R&D to Drive Long-Term Innovation: Management plans double-digit increases in R&D spending, targeting digital platforms (DS Core), implants, and orthodontics. This underscores a strategic shift toward innovation-led growth rather than relying solely on cost optimization.The company aims to accelerate previously delayed projects and enhance product ecosystems, particularly in connected dentistry workflows.

While benefits are expected beyond 2026, increased investment improves competitive positioning against emerging lower-cost players and supports pricing power in premium segments, reinforcing long-term revenue durability.

Dealer Network Expansion Enhancing Commercial Reach: New and expanded agreements with key distributors such as Patterson, Benco and Burkhart mark a strategic pivot toward a broader multichannel distribution model. This should improve market penetration, particularly in capital equipment (CTS segment), where dealer reach is critical.

Management expects these partnerships to contribute meaningfully from late 2026, creating a stronger sales pipeline. Combined with internal sales force restructuring, this hybrid model could significantly enhance U.S. growth trajectory, which remains a central pillar of the turnaround strategy.

Cost Restructuring and Promising Capital Allocation: The company is targeting $120 million in annual cost savings through restructuring, with funds reinvested into growth initiatives. The elimination of dividends reallocates ~$130 million annually toward debt reduction and share repurchases, signaling a more aggressive shareholder return strategy.

This shift, combined with improving operational discipline and working capital initiatives, positions Dentsply to enhance free cash flow generation over time, supporting both deleveraging and equity value creation.

Downsides for XRAYNear-Term Revenue Decline Reflects Ongoing Business Weakness: The projected 1–3% operational sales decline in 2026 reflects ongoing near-term pressure from Byte headwinds, dealer inventory adjustments, and soft demand. Volume declines in key segments such as CAD/CAM and implants further reinforce this trend. Although management anticipates a second-half recovery, the weak base points to execution risk and a gradual recovery trajectory.

Margin Pressure From Tariffs, Mix and Volume Declines: Adjusted EBITDA margins declined due to gross margin compression (down nearly 300 bps), caused by tariffs, unfavorable product mix and lower volumes. Tariffs alone impacted gross profit by approximately $15 million in the fourth quarter and $23 million for the full year.

Continued exposure to external cost pressures, combined with increased R&D and commercial investments, could limit margin recovery in the near term, even as restructuring efforts aim to offset these headwinds.

Weakness in Core Segments, Particularly Implants and Orthodontics: Several core growth engines remain under pressure, including implants (declining volumes globally) and SureSmile aligners (down 10% in U.S. market). Competitive intensity, particularly from lower-cost providers, and changing demand dynamics in China are weighing on performance.

Management acknowledged that orthodontics will require longer-term investment, particularly in software modernization, indicating delayed recovery. Persistent underperformance in these segments could hinder overall revenue stabilization and dilute returns on increased investment.

XRAY’s Estimate TrendThe Zacks Consensus Estimate for 2026 revenues is pegged at $3.57 billion, indicating a 2.9% decrease from the 2025 level.

The consensus mark for adjusted earnings per share is pinned at $1.43 for 2026, indicating a 10.6% year-over-year decline.

Stocks to ConsiderSome better-ranked stocks in the broader medical space are McKesson (MCK - Free Report) , Align Technology (ALGN - Free Report) and Cardinal Health (CAH - Free Report) .

McKesson, currently carrying a Zacks Rank #2 (Buy), has an estimated long-term growth rate of 15.9%. MCK’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 3.60%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

McKesson’s shares have gained 5.5% against the industry’s 4.5% decline year to date.

Align Technology, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 10.1%. ALGN’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 6.16%.

ALGN’s shares have climbed 9.8% against the industry’s 4.5% declin so far this year.

Cardinal Health, currently carrying a Zacks Rank of 2, has an estimated long-term growth rate of 15%. CAH’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 9.3%.

CAH’s shares have gained 2.2% against the industry’s 4.5% decline so far this year.

April 22, 2026 16:15 ET  | Source: DENTSPLY SIRONA Inc.

CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call.

Conference Call / Webcast Information

The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register here. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information

Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]

Dentsply International (XRAY - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on May 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis dental products manufacturer is expected to post quarterly earnings of $0.28 per share in its upcoming report, which represents a year-over-year change of -34.9%.

Revenues are expected to be $841.53 million, down 4.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 3.88% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Dentsply?For Dentsply, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.98%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Dentsply will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Dentsply would post earnings of $0.28 per share when it actually produced earnings of $0.27, delivering a surprise of -3.57%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Dentsply appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Key Takeaways XRAY is set to report Q1 2026 results on May 5, with revenue seen near $840.1M.XRAY faces U.S. demand softness, tariffs and inventory shifts impacting volumes and margins.XRAY sees resilience abroad, while transformation investments pressure near-term earnings. DENTSPLY SIRONA Inc. (XRAY - Free Report) is scheduled to release first-quarter 2026 results on May 5, after market close.

In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 3.57%. It delivered an average earnings surprise of 7.73% for the trailing four quarters.

XRAY’s Q1 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $840.1 million. The consensus mark for earnings is pinned at 28 cents per share.

Our model estimates for revenues and adjusted earnings per share (EPS) are pinned at $846.2 million and 32 cents, respectively.

Factors to Note Ahead of XRAY’s Q1 ResultsDENTSPLY SIRONA’s first-quarter 2026 performance is likely have to reflected continued softness in the United States, along with lingering tariff-related pressures. The company remains in the early phase of executing its multi-year “Return-to-Growth” transformation plan, which is expected to weigh on near-term earnings due to elevated investments in innovation, commercial reorganization and clinical education. While these actions are aimed at restoring sustainable growth, they are likely to have kept margins under pressure in the to-be-reported quarter.

Tariffs and softer demand trends in key categories like equipment, implants and CAD/CAM solutions are expected to continue in the U.S. market. Management also highlighted a headwind from dealer inventory adjustments, particularly tied to a shift toward a drop-ship model, with roughly $30 million of inventory expected to be worked down in the first half of 2026. These dynamics are likely to have weighed on volumes and revenue visibility in the quarter to be reported.

From a segmental standpoint, ongoing weakness in Connected Technology Solutions, implants and orthodontics is likely to have persisted, given competitive pressures and lower procedural volumes. However, relatively stable trends in Essential Dental Solutions, along with continued strength in Wellspect Healthcare, may have provided some support. Distributor inventory levels for equipment and CAD/CAM remained below historical averages exiting 2025, indicating that any recovery is likely to be gradual and dependent on dealer reengagement efforts.

On the geographic front, while the U.S. business is expected to have remained under pressure, international markets — particularly Europe — likely continued to demonstrate resilience. Management previously indicated stable end-market conditions outside the United States, which may have helped partially offset domestic weakness in the quarter.

Investors are likely to closely monitor signs of stabilization in the U.S. market, progress on dealer partnerships, execution in the implants business and early traction from commercial restructuring initiatives. Although management expects sequential improvement in the second half of 2026, the first quarter is likely to have reflected a transition phase, with benefits from strategic initiatives yet to fully materialize.

What the Zacks Model Unveils for XRAYOur proven model does not conclusively predict an earnings beat for XRAY this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here, as you will see below.

XRAY’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +1.98%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

XRAY’s Zacks Rank: DENTSPLY SIRONA currently carries a Zacks Rank #4 (Sell).

Stocks to ConsiderHere are some medical product stocks worth considering, as these have the right combination of elements to post an earnings beat this reporting cycle.

Microbot Medical (MBOT - Free Report) has an Earnings ESP of +8.70% and a Zacks Rank of 2 at present.

MBOT’s earnings surpassed estimates in two of the trailing four quarters and missed twice, with the average surprise being 7.53%. The Zacks Consensus Estimate for MBOT’s first-quarter loss per share implies no change from the year-ago reported figure.

Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.28% and a Zacks Rank #3 at present. The company is slated to release first-quarter 2026 results on May 5.

HSIC’s earnings surpassed estimates in three of the trailing four quarters and missed once, with the average surprise being 2.14%. The Zacks Consensus Estimate for HSIC’s first-quarter EPS indicates an improvement of 4.4% from the year-ago reported figure.

IDEXX Laboratories (IDXX - Free Report) has an Earnings ESP of +0.77% and a Zacks Rank of 3 at present. The company is slated to release first-quarter 2026 results on May 5.

IDXX’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 6.11%. The Zacks Consensus Estimate for IDXX’s first-quarter EPS indicates a gain 15.5% from the year-ago reported figure.

News Summary

Reported net sales of $880 millionDelivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across EuropeContinued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreementInstalled first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestoneBegan implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capitalReiterated 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026.

“We are executing our Return-to-Growth Action Plan as expected, and our first quarter results reflect our current stage of transformation,” said Dan Scavilla, President and Chief Executive Officer of Dentsply Sirona. “While near-term performance is impacted by external pressures and investment timing, we are making solid progress toward sustainable growth.

"During the quarter, we advanced our commercial restructuring and continued portfolio innovation, with early traction from distributor partners. We remain confident in our strategy, maintain our full-year outlook, and expect momentum to build throughout the year.”

Q1 2026 Summary Results (Reported)

(in millions, except per share amount and percentages) Q1 26 Q1 25 YoY       Net Sales $880 $879 0.1%Gross Profit $427 $466 (8.3%)Gross Margin 48.5% 53.0%  Net (Loss) Income Attributable to Dentsply Sirona ($10) $20 NMDiluted (Loss) Earnings Per Share1 ($0.05) $0.10 NM        Q1 2026 Summary Results (Non-GAAP)

(in millions, except per share amount and percentages) Q1 26 Q1 25 YoY       Constant Currency Sales     (6.7%)Adjusted EBITDA $129 $168 (22.8%)Adjusted EBITDA Margin 14.7% 19.0%  Adjusted EPS $0.27 $0.44 (39.0%)        NM - not meaningful
Percentages are based on actual values and may not reconcile due to rounding.
[1] Weighted-average shares outstanding used to calculate diluted loss per share for the first quarter of 2026 excludes potential dilutive common shares.

New Regional Reporting

Beginning in the three months ended March 31, 2026, the Company's geographic regions for reporting net sales were revised to consist of countries in (i) North and South America ("Americas"), (ii) Europe, the Middle East, and Africa ("EMEA"), and (iii) Asia Pacific ("APAC"). The revised regions align with how the Company manages commercial activities and reports net sales internally. This change did not impact the Company's consolidated financial statements and prior period amounts have been recast to conform to the current period presentation.

     Percentage ChangeNet Sales by Segment(in millions, except percentages) Three Months Ended March 31,
2026 vs. 2025        Americas EMEA APAC                 2026
 2025
 As
Reported1Constant Currency1 As
ReportedConstant Currency As
ReportedConstant Currency As
ReportedConstant Currency                Connected Technology Solutions$246 $235 4.4%(2.9)% 1.9%(1.1)% 7.0%(5.5)% 3.1%0.1%Essential Dental Solutions 350  353 (0.9)%(7.2)% (7.3)%(8.5)% 2.0%(10.5)% 17.3%12.6%Orthodontic and Implant Solutions 199  217 (8.1)%(13.5)% (23.7)%(24.2)% 7.1%(4.5)% (2.5)%(5.7)%Wellspect Healthcare 85  74 15.0%3.4% (3.2)%(0.6)% 18.2%4.0% 12.2%10.6%Total$880 $879 0.1%(6.7)% (9.4)%(10.7)% 6.9%(5.6)% 6.3%2.7%                          (1) Constant currency sales are a Non-GAAP measure in which the reported net sales are adjusted for the impact of foreign currency changes, which is calculated by translating current period net sales using the comparable prior period’s currency exchange rates. The foreign currency impact is the only reconciling item between as reported and constant currency sales.  Cash Flow and Liquidity

Operating cash flow in the first quarter of 2026 was $40 million, compared to $7 million in the first quarter of 2025, primarily due to favorable collections on accounts receivable. Free cash flow, a Non-GAAP measure, in the first quarter of 2026 was ($12) million compared to ($12) million in the first quarter of 2025. The Company had $190 million of cash and cash equivalents as of March 31, 2026.

2026 Outlook

The Company is maintaining its 2026 outlook for net sales in the range of $3.5 billion to $3.6 billion and adjusted EPS in the range of $1.40 to $1.50.

We are unable to present a quantitative reconciliation of our expected earnings per diluted share to expected adjusted earnings per diluted share as we are unable to predict with reasonable certainty and without unreasonable effort, items which may include, but are not limited to, restructuring charges, transformation-related costs, impairment charges, certain tax adjustments, and other significant items. The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Operations.

Conference Call/Webcast Information
Dentsply Sirona's management team will host an investor conference call and live webcast on May 5, 2026, at 4:30 p.m. ET. The live webcast and a presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at http://register-conf.media-server.com/register/BIc1c93f4a84c14e3ea70e14bf07b0e306. A webcast replay of the conference call will be available on the Investors section of the Company's website following the call.

About Dentsply Sirona

Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information:
Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]

Press:
Marion Par-Weixlberger
Vice President, Public Relations, Corporate Communications & Brand
[email protected]

Forward-Looking Statements and Associated Risks

All statements in this Press Release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described in Part I, Item 1A, "Risk Factors" of the Company's most recent Annual Report on Form 10-K, Part II, Item 1A, "Risk Factors" of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the "SEC"). No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Press Release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.

DENTSPLY SIRONA INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share amounts)
(unaudited)

 Three Months Ended March 31,  2026   2025 Net sales$880  $879 Cost of products sold 453   413     Gross profit 427   466     Selling, general, and administrative expenses 351   358 Research and development expenses 44   36 Restructuring and other costs 67   9     Operating (loss) income (35)  63     Other income and expenses:   Interest expense, net 24   19 Other (income) expense, net (17)  —     (Loss) income before income taxes (42)  44 (Benefit) provision for income taxes (32)  25     Net (loss) income (10)  19     Less: Net loss attributable to noncontrolling interest —   (1)    Net (loss) income attributable to Dentsply Sirona$(10) $20     (Loss) earnings per common share attributable to Dentsply Sirona:   Basic$(0.05) $0.10 Diluted$(0.05) $0.10     Weighted average common shares outstanding:   Basic 199.9   199.1 Diluted 199.9   199.8  DENTSPLY SIRONA INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share amounts)
(unaudited)

 March 31, 2026 December 31, 2025    Assets   Current Assets:   Cash and cash equivalents$190 $326Accounts and notes receivable-trade, net 622  688Inventories, net 659  642Prepaid expenses and other current assets 374  367Total Current Assets 1,845  2,023    Property, plant, and equipment, net 858  861Operating lease right-of-use assets, net 139  139Identifiable intangible assets, net 924  974Goodwill 1,142  1,148Other noncurrent assets 321  284Total Assets$5,229 $5,429    Liabilities and Equity   Current Liabilities:   Accounts payable$259 $300Accrued liabilities 688  700Income taxes payable 30  30Notes payable and current portion of long-term debt 230  313Total Current Liabilities 1,207  1,343    Long-term debt 2,006  2,015Operating lease liabilities 95  93Deferred income taxes 84  94Other noncurrent liabilities 518  544Total Liabilities 3,910  4,089    Total Equity 1,319  1,340    Total Liabilities and Equity$5,229 $5,429 DENTSPLY SIRONA INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)

 Three Months Ended March 31,  2026   2025     Cash flows from operating activities:   Net (loss) income$(10) $19     Adjustments to reconcile net loss to net cash provided by operating activities:   Depreciation 38   34 Amortization of intangible assets 41   45 Deferred income taxes (60)  1 Stock-based compensation expense 8   10 Other non-cash (income) expense (15)  9 Gain on disposal of assets (6)  — Changes in operating assets and liabilities:   Accounts and notes receivable-trade, net 60   (31)Inventories, net (23)  (26)Prepaid expenses and other current assets 19   (1)Other noncurrent assets 1   4 Accounts payable 2   14 Accrued liabilities (20)  (44)Income taxes 7   (12)Other noncurrent liabilities (2)  (15)Net cash provided by operating activities 40   7     Cash flows from investing activities:   Capital expenditures (52)  (19)Net investment hedge settlements (7)  — Other investing activities 6   2 Net cash used in investing activities (53)  (17)    Cash flows from financing activities:   Proceeds from 364-day bridge loan —   435 Repayments on short-term borrowings (51)  (272)Cash dividends paid (32)  (32)Repayments on long-term borrowings (31)  (2)Cash paid for deferred financing costs —   (3)Other financing activities, net (5)  (3)Net cash (used in) provided by financing activities (119)  123 Effect of exchange rate changes on cash and cash equivalents (4)  13 Net (decrease) increase in cash and cash equivalents (136)  126 Cash and cash equivalents at beginning of period 326   272 Cash and cash equivalents at end of period$190  $398     Supplemental disclosures of cash flow information:   Interest paid, net of amounts capitalized$44  $13 Non-cash investing activities:   Property, plant and equipment in accounts payable at end of period$29  $22 Exchange of inventory for naming and other rights$—  $14  Supplemental Information – Reconciliation of GAAP to Non-GAAP Financial Measures

We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (“GAAP”) with certain non-GAAP financial measures, including percentage sales growth in constant currency; adjusted gross profit; adjusted gross profit as a percent of net sales (“Adjusted Gross Margin”); adjusted operating income; adjusted operating income as a percent of net sales (“Adjusted Operating Margin”); adjusted earnings before interest expense, income taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA as a percent of net sales (“Adjusted EBITDA Margin”); adjusted net income (loss); adjusted earnings (loss) per diluted share (“Adjusted EPS”); and Free Cash Flow. These non-GAAP financial measures are used by the Company to measure its performance and management believes these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes percentage sales growth in constant currency and the other adjusted measures described above are important indicators of our operations because they exclude items that may not be indicative of or are unrelated to our core operating results and provide a baseline for analyzing trends in our underlying businesses. Management uses these non-GAAP financial measures for reviewing the operating results of reportable business segments and analyzing potential future business trends in connection with our budget process and bases certain management incentive compensation on these non-GAAP financial measures.

The Company has defined the non-GAAP measures used by management as follows:

Constant Currency: reported net sales adjusted for the impact of foreign currency changes, which is calculated by translating current period net sales using the comparable period's foreign currency exchange rates.Adjusted Operating Income and Margin: Adjusted operating income is computed by excluding the following items from operating income (loss) as reported in accordance with US GAAP. Adjusted operating margin is calculated by dividing adjusted operating income by net sales. Business combination-related costs: costs related to consummating and integrating acquired businesses, as well as net gains and losses related to disposed businesses. Costs include the post-acquisition roll-off of fair value adjustments recorded related to business combinations, except for amortization expense of purchased intangible assets noted below.Restructuring-related charges and other costs: costs related to the implementation of restructuring initiatives, including but not limited to, severance costs, facility closure costs, and lease and contract termination costs, as well as related professional service costs associated with these restructuring initiatives and global transformation activity. Other costs include gains and losses on the sale of property, legal settlements, executive separation costs, write-offs of inventory as a result of product rationalization, and changes in accounting principles recorded within the period. This category also includes costs related to investigations and associated legal cases and remediation activities, which primarily include legal, accounting and other professional service fees, as well as turnover and other employee-related costs.Goodwill and intangible asset impairments: include charges related to goodwill and intangible asset impairments.Amortization of purchased intangible assets: includes the periodic amortization expense related to purchased intangible assets, which are recorded at fair value.Fair value and credit risk adjustments: include the non-cash mark-to-market changes in fair value associated with pension assets and obligations, the credit risk component of hedging instruments, contingent consideration from past acquisitions, and equity-method investments. Adjusted Gross Profit and Margin: gross profit excluding the impact of any of the above adjustments that affect either net sales or cost of sales. Adjusted gross margin is calculated by dividing adjusted gross profit by net sales.Adjusted Net Income (Loss): net income (loss) as reported in accordance with US GAAP, adjusted to exclude the items identified above and the related income tax impacts of those items, as well as the tax effects of certain significant and discrete tax adjustments, including benefits and provisions related to changes in realization of deferred tax assets and tax credit carryforwards, as well as other events that affect comparability and are not core to our underlying operational performance.Adjusted EBITDA and Margin: in addition to the adjustments described above in arriving at adjusted net income, adjusted EBITDA is computed by further excluding any remaining interest expense, net, income tax expense, depreciation and amortization. Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by net sales.Adjusted Earnings (Loss) Per Diluted Share: computed by dividing adjusted earnings (loss) attributable to Dentsply Sirona stockholders by the diluted weighted average number of common shares outstanding.Free Cash Flow: net cash provided by operating activities minus capital expenditures during the same period. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names. These adjusted financial measures should not be considered in isolation or as a substitute for the most directly comparable GAAP financial measures. These non-GAAP financial measures are an additional way of viewing aspects of our operations that, when viewed with our GAAP results and the reconciliations to corresponding GAAP financial measures below, provide a more complete understanding of our business. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.

The following reconciles the non-GAAP financial measures discussed above with the most directly comparable GAAP financial measures. The weighted-average diluted shares outstanding used in the calculation of adjusted net earnings per diluted share are the same as those used in the calculation of reported net earnings per diluted share for the respective period. The weighted-average diluted shares outstanding used in the calculation of adjusted net loss per diluted share excludes potential dilutive common shares.

DENTSPLY SIRONA INC. AND SUBSIDIARIES
(in millions, except per share amounts and percentages)
(unaudited)  Beginning in fiscal year 2026, the Company updated its definition of Adjusted Net Income (Loss), a non-GAAP financial measure, to include adjustments for certain significant and discrete tax items, including benefits and provisions related to changes in the realization of deferred tax assets and tax credit carryforwards, as well as other tax‑related items that affect comparability and are not considered part of the Company’s core operational performance. Prior-period information below has been updated to conform to current period presentation. A reconciliation of selected items as reported in the Condensed Consolidated Statements of Operations to adjusted Non-GAAP financial statements items are as follows:

Three Months Ended March 31, 2026 Gross Profit Operating
(Loss) Income (Benefit)
Provision for
Income Taxes Net (loss)
Income
Attributable to
Dentsply Sirona Diluted (Loss)
Earnings per
ShareReported $427  $(35) $(32) $(10) $(0.05)Reported percent net sales  48.5%  (4.0%)      Non-GAAP Adjustments:          Amortization of Purchased Intangible Assets  19   42   11   31   0.15 Restructuring-Related Charges and Other Costs (a) (b)  1   74   18   50   0.25 Income Tax-Related Adjustments (c)  —   —   17   (17)  (0.08)Adjusted $447  $81  $14  $54  $0.27 Adjusted percent net sales  50.7%  9.2%      Weighted average common shares outstanding used in calculating diluted GAAP net loss per common share  199.9 Weighted average common shares outstanding used in calculating diluted Non-GAAP net income per common share  201.1 (a) Restructuring‑Related Charges and Other Costs includes $60 of costs associated with the 2026 restructuring plan as well as costs from other restructuring actions and the new global ERP system. These amounts are on a pre-tax basis.  (b) Amounts will not cross foot due to a $6 gain on an asset divestiture that is presented in Other income and expense.  (c) Income Tax-Related Adjustments includes adjustments for decreased valuation allowances for Brazil of $27 and Luxembourg of $7, along with increased valuation allowances for Germany of $4 and Switzerland of $3, and other various tax adjustments. Percentages are based on actual values and may not reconcile due to rounding.

Three Months Ended March 31, 2025 Gross Profit Operating (loss)
income (Benefit)
Provision for
Income Taxes Net Income
Attributable to
Dentsply Sirona Diluted
Earnings per
ShareReported $466  $63  $25  $20 $0.10Reported percent net sales  53.0%  7.1%      Non-GAAP Adjustments:          Amortization of Purchased Intangible Assets  28   45   12   33  0.16Restructuring-Related Charges and Other Costs (a)  —   25   6   19  0.10Business Combination-Related Costs  1   1   —   1  —Income Tax-Related Adjustments (b)  —   —   (15)  15  0.08Adjusted $495  $134  $28  $88 $0.44Adjusted percent net sales  56.3%  15.1%      Weighted average common shares outstanding used in calculating diluted GAAP net income per common share  199.8Weighted average common shares outstanding used in calculating diluted Non-GAAP net income per common share  199.8(a) Restructuring‑Related Charges and Other Costs includes $6 of costs associated with the 2024 restructuring plan, $8 of costs associated with legal fees and investigation costs, and other costs related to global supply chain transformation and the new global ERP system. These amounts are on a pre-tax basis.  (b) Income Tax-Related Adjustments includes adjustments for increased valuation allowances for Germany of $6 and Switzerland of $1, and other various tax adjustments. Percentages are based on actual values and may not reconcile due to rounding.

DENTSPLY SIRONA INC. AND SUBSIDIARIES
(in millions, except per share amounts and percentages)
(unaudited)  Reconciliations of reported net (loss) income attributable to Dentsply Sirona to adjusted EBITDA and margin are as follows:

  Three Months Ended March 31,   2026   2025      Net (loss) income attributable to Dentsply Sirona $(10) $20 Interest expense, net  24   19 (Benefit) provision for income taxes  (32)  25 Depreciation(1)  38   33 Amortization of intangible assets  41   45 Restructuring-related charges and other costs  68   25 Business combination-related costs and fair value adjustments  —   1 Adjusted EBITDA $129  $168      Net sales $880  $879 Adjusted EBITDA margin  14.7%  19.0% (1) Excludes those depreciation-related amounts which were included as part of the business combination-related adjustments and Restructuring-related charges and other costs.
Percentages are based on actual values and may not reconcile due to rounding.

A reconciliation of free cash flow for the three months ended March 31, 2026 and 2025 is as follows:

  Three Months Ended March 31,   2026   2025      Net cash provided by operating activities $40  $7 Capital expenditures  (52)  (19)Free cash flow $(12) $(12)

For the quarter ended March 2026, Dentsply International (XRAY - Free Report) reported revenue of $880 million, up 0.1% over the same period last year. EPS came in at $0.27, compared to $0.43 in the year-ago quarter.

The reported revenue represents a surprise of +5.12% over the Zacks Consensus Estimate of $837.11 million. With the consensus EPS estimate being $0.28, the EPS surprise was -3.95%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net sales- Connected Technology Solutions: $246 million versus $216.47 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.7% change.Net sales- Wellspect Healthcare: $85 million compared to the $76.62 million average estimate based on five analysts. The reported number represents a change of +14.9% year over year.Net sales- Essential Dental Solutions: $350 million versus $343.09 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -0.9% change.Net sales- Orthodontic and Implant Solutions: $199 million versus the five-analyst average estimate of $198.96 million. The reported number represents a year-over-year change of -8.3%.View all Key Company Metrics for Dentsply here>>>

Shares of Dentsply have returned -3.8% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Key Takeaways XRAY Q1 adjusted EPS fell 39% year over year and missed analyst estimates.DENTSPLY SIRONA margin contracted as lower volumes and tariffs weighed on profits.XRAY maintained 2026 sales and EPS outlook despite softer demand in Europe. DENTSPLY SIRONA Inc. (XRAY - Free Report) reported first-quarter 2026 adjusted earnings per share (EPS) of 27 cents, down 39% year over year. The bottom line missed the Zacks Consensus Estimate by 3.6%.

GAAP loss per share in the quarter under review was 5 cents against EPS of 10 cents in the prior-year quarter.

DENTSPLY SIRONA’s RevenuesRevenues totaled $880 million in the reported quarter, up 0.1% year over year reportedly but down 6.7% at constant currency (cc). The metric beat the Zacks Consensus Estimate by 5.1%.

The top line was driven by strength in Connected Technology Solutions and Wellspect Healthcare segments, partially offset by weakness in Essential Dental Solutions and Orthodontic and Implant Solutions segments.

Shares of XRAY declined 0.6% in yesterday’s after-market trading. The stock has lost 0.6% year to date compared with the industry’s 7.3% decline. The S&P 500 Index has increased 6% in the same period.

Image Source: Zacks Investment Research

XRAY’s Segmental AnalysisDENTSPLY SIRONA generates revenues under four segments — Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.

Connected Technology Solutions segment’s revenues in the first quarter of 2026 totaled $246 million, up 4.4% but down 2.9% year over year on a reported and constant-currency basis, respectively. Our projection was $227.8 million for the metric.

Essential Dental Solutions segment’s revenues totaled $350 million, down 0.9% year over year on a reported basis and 7.2% at cc. Our projection was $341.2 million for the metric.

Orthodontic and Implant Solutions segment’s revenues amounted to $199 million, down 8.1% and 13.5% year over year on a reported basis and at cc, respectively. Our projection for the metric was $197.9 million.

Wellspect Healthcare segment’s revenues totaled $85 million, up 15% and 3.4% year over year on a reported basis and at cc, respectively. Our projection was $79.2 million for the metric.

DENTSPLY SIRONA’s Geographic RevenuesBeginning first-quarter 2026, DENTSPLY SIRONA started reporting under new regional segments as follows — North and South America as Americas, Europe, the Middle East, and Africa (“EMEA”) and Asia Pacific (“APAC”). The company used to report under US, Europe and Rest of World geographic segments.

Revenues from Americas were down 9.1% year over year on a reported basis and 10.7% at cc.

Revenues from EMEA were up 6.9% year over year on a reported basis but down 5.6% at cc.

Revenues from APAC improved 6.3% year over year on a reported basis and 2.7% at cc.

XRAY’s Margin AnalysisIn the quarter under review, DENTSPLY SIRONA’s adjusted gross profit declined 9.7% year over year to $447 million. The adjusted gross margin contracted 560 basis points (bps) to 50.7%. We had projected an adjusted gross margin of 52.5% for the first quarter.

Selling, general, and administrative expenses decreased 2% year over year to $351 million. Research and development expenses increased 22.2% to $44 million. Adjusted operating expenses increased 1.4% year over year to $366 million.

Adjusted operating profit totaled $81 million, reflecting a 39.6% decrease from the prior-year quarter’s level. The adjusted operating margin contracted 590 bps to 9.2%. We had projected an adjusted operating margin of 12.7% for the first quarter.

DENTSPLY SIRONA’s Financial UpdateThe company exited first-quarter 2026 with cash and cash equivalents worth $190 million compared with $326 million at the end of the fourth quarter of 2025. Total debt was $2.24 billion compared with $2.33 billion in the previous quarter.

Cumulative net cash provided by operating activities at the end of first-quarter 2026 was $40 million compared with $7 million in the prior-year period.

DENTSPLY SIRONA has a consistent dividend-paying history, with its five-year annualized dividend growth being 9.5%.

XRAY’s GuidanceDENTSPLY SIRONA has maintained its 2026 sales and earnings outlook.

The company continues to expect full-year sales in the range of $3.5 billion to $3.6 billion. The Zacks Consensus Estimate is currently pegged at $3.57 billion.

XRAY continues to expect 2026 adjusted EPS in the range of $1.40-$1.50. The Zacks Consensus Estimate is currently pegged at $1.43.

Our Take on DENTSPLY SIRONADENTSPLY SIRONA ended the first quarter of 2026 on a mixed note, with earnings missing estimates but sales beating the same as the company began executing its “Return-to-Growth” strategy. First-quarter revenues were broadly flat, while constant-currency sales declined, pressured by weakness in consumables, implants and orthodontics, along with ongoing dealer destocking in Europe and lower Byte-related sales. Adjusted EBITDA margin contracted sharply due to lower volumes, unfavorable mix and tariff impacts. Still, management highlighted encouraging early traction from commercial restructuring, expanded distributor partnerships and disciplined cost controls, which reduced operating expenses by roughly $20 million in the quarter.

XRAY expects improvement to build gradually through the second half of 2026 and into 2027, supported by new product launches, AI-enabled diagnostics, expanded clinical education and a broader U.S. distribution network. Strategic focus on implants, endodontics and digital workflows could strengthen long-term growth, while restructuring initiatives are expected to generate approximately $120 million in annual savings.

However, notable challenges persist, including macroeconomic uncertainty, competitive pricing pressure in digital dentistry, tariff-driven cost inflation and uneven demand trends across Europe. Nevertheless, management reaffirmed its full-year guidance, signaling confidence in its turnaround strategy and execution.

XRAY’s Zacks Rank and Stocks to ConsiderDENTSPLY SIRONA currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the broader medical space that have announced quarterly results are West Pharmaceutical Services, Inc. (WST - Free Report) , Intuitive Surgical (ISRG - Free Report) and Cardinal Health, Inc. (CAH - Free Report) .

West Pharmaceutical reported first-quarter 2026 earnings per share (EPS) of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

West Pharmaceutical has a long-term estimated growth rate of 13.9%. WST’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.37%.

Intuitive Surgical reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.19%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%. It currently carries a Zacks Rank of 2 (Buy).

Intuitive Surgical has a long-term estimated growth rate of 14.9%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.82%.

Cardinal Health, carrying a Zacks Rank of 2 at present, reported third-quarter fiscal 2026 adjusted EPS of $3.17, which beat the Zacks Consensus Estimate by 13.2%. Revenues of $60.94 billion missed the Zacks Consensus Estimate by 2.3%.

Cardinal Health has a long-term estimated growth rate of 15.6%. CAH’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.27%.

May 26, 2026 16:30 ET  | Source: DENTSPLY SIRONA Inc.

CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced the strengthening of its U.S. distribution footprint through an expanded partnership with Nashville Dental, Inc (NDI), a leading independent dental distributor serving the Southeast and Mid-Atlantic regions.

As of August 1, 2026, NDI’s portfolio will include Dentsply Sirona’s full range of connected technology solutions, including the CEREC system, Primescan intraoral scanners, and digital imaging solutions. This expansion allows dental practices across a nine-state territory to access the company’s advanced digital dentistry technologies through an additional trusted local distributor.

“As demand for digital dentistry continues to evolve, expanding access through trusted, regionally embedded distributors remains a priority,” said Mark Bezjak, Group Vice President, Americas, Dentsply Sirona. “This agreement advances the execution of our connected technology strategy in the U.S. by bringing integrated solutions closer to customers through proven local partners.”

NDI, a long-established, full-service organization with a strong presence across multiple Southeastern and Mid-Atlantic markets, provides comprehensive support spanning equipment technology, installation, service, and practice advisory services. By expanding its technology portfolio, the company will offer customers broader access to digitally connected workflows, while maintaining localized service and support.

The agreement underscores Dentsply Sirona’s continued focus on strengthening its U.S. go-to-market model through a balanced mix of direct and indirect channels, designed to support growth, improve customer accessibility, and drive adoption of digitally integrated dental solutions.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information:

Dentsply Sirona Press Contact:
Marion Par-Weixlberger
Vice President, Corporate Communications, Public Relations & Brand
[email protected] | www.dentsplysirona.com

Dentsply Sirona Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]

It has been about a month since the last earnings report for Dentsply International (XRAY - Free Report) . Shares have lost about 13.5% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Dentsply due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important drivers.

XRAY Stock Down as Q1 Earnings Miss Estimates, Margins ContractDENTSPLY SIRONA reported first-quarter 2026 adjusted earnings per share of 27 cents, down 39% year over year. The bottom line missed the Zacks Consensus Estimate by 3.6%.

GAAP loss per share in the quarter under review was 5 cents against earnings per share of 10 cents in the prior-year quarter.

DENTSPLY SIRONA’s RevenuesRevenues totaled $880 million in the reported quarter, up 0.1% year over year reportedly but down 6.7% at constant currency (cc). The metric beat the Zacks Consensus Estimate by 5.1%.

The top line was driven by strength in Connected Technology Solutions and Wellspect Healthcare segments, partially offset by weakness in Essential Dental Solutions and Orthodontic and Implant Solutions segments.

XRAY’s Segmental AnalysisConnected Technology Solutions segment’s revenues in the first quarter of 2026 totaled $246 million, up 4.4% but down 2.9% year over year on a reported and constant-currency basis, respectively. Our projection was $227.8 million for the metric.

Essential Dental Solutions segment’s revenues totaled $350 million, down 0.9% year over year on a reported basis and 7.2% at cc. Our projection was $341.2 million for the metric.

Orthodontic and Implant Solutions segment’s revenues amounted to $199 million, down 8.1% and 13.5% year over year on a reported basis and at cc, respectively. Our projection for the metric was $197.9 million.

Wellspect Healthcare segment’s revenues totaled $85 million, up 15% and 3.4% year over year on a reported basis and at cc, respectively. Our projection was $79.2 million for the metric.

DENTSPLY SIRONA’s Geographic RevenuesBeginning first-quarter 2026, DENTSPLY SIRONA started reporting under new regional segments as follows — North and South America as Americas, Europe, the Middle East, and Africa (“EMEA”) and Asia Pacific (“APAC”). The company used to report under US, Europe and Rest of World geographic segments.

Revenues from Americas were down 9.1% year over year on a reported basis and 10.7% at cc.

Revenues from EMEA were up 6.9% year over year on a reported basis but down 5.6% at cc.

Revenues from APAC improved 6.3% year over year on a reported basis and 2.7% at cc.

XRAY’s Margin AnalysisIn the quarter under review, DENTSPLY SIRONA’s adjusted gross profit declined 9.7% year over year to $447 million. The adjusted gross margin contracted 560 basis points (bps) to 50.7%. We had projected an adjusted gross margin of 52.5% for the first quarter.

Selling, general, and administrative expenses decreased 2% year over year to $351 million. Research and development expenses increased 22.2% to $44 million. Adjusted operating expenses increased 1.4% year over year to $366 million.

Adjusted operating profit totaled $81 million, reflecting a 39.6% decrease from the prior-year quarter’s level. The adjusted operating margin contracted 590 bps to 9.2%. We had projected an adjusted operating margin of 12.7% for the first quarter.

DENTSPLY SIRONA’s Financial UpdateThe company exited first-quarter 2026 with cash and cash equivalents worth $190 million compared with $326 million at the end of the fourth quarter of 2025. Total debt was $2.24 billion compared with $2.33 billion in the previous quarter.

Cumulative net cash provided by operating activities at the end of first-quarter 2026 was $40 million compared with $7 million in the prior-year period.

XRAY’s GuidanceDENTSPLY SIRONA has maintained its 2026 sales and earnings outlook.

The company continues to expect full-year sales in the range of $3.5 billion to $3.6 billion.

XRAY continues to expect 2026 adjusted EPS in the range of $1.40-$1.50.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.

VGM ScoresCurrently, Dentsply has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. However, the stock was allocated a score of A on the value side, putting it in the top quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Dentsply has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerDentsply is part of the Zacks Medical - Dental Supplies industry. Over the past month, Cardinal Health (CAH - Free Report) , a stock from the same industry, has gained 2.3%. The company reported its results for the quarter ended March 2026 more than a month ago.

Cardinal reported revenues of $60.94 billion in the last reported quarter, representing a year-over-year change of +11%. EPS of $3.17 for the same period compares with $2.35 a year ago.

For the current quarter, Cardinal is expected to post earnings of $2.41 per share, indicating a change of +15.9% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.5% over the last 30 days.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #2 (Buy) for Cardinal. Also, the stock has a VGM Score of A.

CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20.

Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-scale business and finance transformations, capital allocation and portfolio optimization strategies, acquisitions and integrations, and ERP implementations to strengthen financial discipline, drive growth and deliver sustainable shareholder returns. He joins Dentsply Sirona from Kymera International, where he served as CFO. Prior to Kymera, he held executive roles at Ingevity Corporation, starting as CFO & Treasurer before being promoted to CEO, President, and board member.

"We are excited to welcome John to Dentsply Sirona," said Dan Scavilla, President and CEO of Dentsply Sirona. "Following an extensive search, John emerged as the clear choice to serve as our next CFO given his rare combination of public company CFO experience, CEO perspective, capital markets expertise, and a proven track record of driving growth and operational excellence at scale.

“We are confident that John’s collaborative leadership style, strategic mindset, and focus on execution will make him an outstanding partner for our leadership team as we advance our Return-to-Growth Action Plan.”

Mr. Fortson said, "I am honored to join Dentsply Sirona at such an important time for the Company. With leading market positions, innovative products, and significant opportunities ahead, I believe Dentsply Sirona is poised for long-term growth. I look forward to partnering with Dan and the leadership team to strengthen performance, drive disciplined execution across the business and deliver long-term growth and value creation for shareholders."

About John Fortson
Most recently, Mr. Fortson served as President and CFO of Kymera International, a global specialty materials company, backed by Palladium Equity Partners and Goldman Sachs. During his tenure, he helped lead the integration of a rapidly expanded global platform spanning 21 manufacturing facilities across 14 countries while overseeing the consolidation of 12 ERP systems into a unified operating environment and driving initiatives to improve forecasting, liquidity, working capital performance, and operational efficiency.

Prior to Kymera, Mr. Fortson spent nearly a decade at Ingevity Corporation (NYSE: NGVT), a global specialty chemicals and materials company with approximately $1.3 billion in annual revenue, serving first as CFO and later as President, CEO and a member of the company’s board. While at Ingevity, he led the successful separation from WestRock, built its finance, treasury, tax, investor relations, internal audit, and information technology capabilities to support a standalone public company, and helped establish a robust capital structure through a $700 million credit facility, $300 million high-yield bond offering, and more than $1 billion of strategic acquisitions.

Earlier in his career, Mr. Fortson served as CFO of AAR Corp., a leading global aviation services company with more than $2 billion in annual revenue. There, he led a comprehensive portfolio transformation that included divesting non-core manufacturing assets, retiring $325 million of debt, returning more than $150 million to shareholders through share repurchases, improving returns on invested capital, and repositioning the company around its higher-value aviation services platform.

Before entering corporate leadership, Mr. Fortson spent 15 years in investment banking at Bank of America Merrill Lynch, ultimately serving as Managing Director in the Industrials Group. Prior to his investment banking career, he served as an officer in the U.S. Army for seven years.

Mr. Fortson holds a Master of Business Administration from Duke University's Fuqua School of Business and a Bachelor of Science from the United States Military Academy at West Point.

About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]

Press:
Marion Par-Weixlberger
Vice President, Public Relations, Corporate Communications & Brand
[email protected]

Forward-Looking Statements and Associated Risks
All statements in this Press Release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described in Part I, Item 1A, "Risk Factors" of the Company's most recent Annual Report on Form 10-K, Part II, Item 1A, "Risk Factors" of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the "SEC"). No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Press Release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e933748c-1d1e-42ca-9ca8-589a7ef272f0

John Fortson, Chief Financial Officer John Fortson, Chief Financial Officer

Posted by Defense World Staff on Apr 20th, 2026

Yelp Inc. (NYSE:YELP – Get Free Report) CFO David Schwarzbach sold 7,500 shares of the stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $26.60, for a total transaction of $199,500.00. Following the completion of the transaction, the chief financial officer directly owned 209,300 shares in the company, valued at $5,567,380. The trade was a 3.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yelp Price Performance Shares of NYSE:YELP opened at $27.92 on Monday. The company’s fifty day moving average price is $23.93 and its 200-day moving average price is $27.91. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 12.41, a PEG ratio of 0.70 and a beta of 0.47. Yelp Inc. has a one year low of $19.60 and a one year high of $41.22.

Yelp (NYSE:YELP – Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The local business review company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.47 by $0.14. The firm had revenue of $359.99 million for the quarter, compared to analyst estimates of $358.70 million. Yelp had a net margin of 9.94% and a return on equity of 19.96%. The business’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.62 EPS. As a group, equities research analysts expect that Yelp Inc. will post 2.22 EPS for the current year.

Analysts Set New Price Targets YELP has been the topic of a number of research analyst reports. Robert W. Baird set a $25.00 price target on shares of Yelp in a report on Friday, February 13th. Weiss Ratings cut shares of Yelp from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, February 11th. JPMorgan Chase & Co. reduced their price target on shares of Yelp from $30.00 to $22.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 17th. The Goldman Sachs Group reduced their price target on shares of Yelp from $33.00 to $25.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 17th. Finally, Morgan Stanley reduced their price target on shares of Yelp from $30.00 to $28.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 13th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $28.50.

Read Our Latest Stock Report on YELP

Institutional Trading of Yelp A number of institutional investors have recently made changes to their positions in the stock. California State Teachers Retirement System boosted its stake in shares of Yelp by 0.7% during the second quarter. California State Teachers Retirement System now owns 58,298 shares of the local business review company’s stock valued at $1,998,000 after purchasing an additional 393 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Yelp by 6.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the local business review company’s stock valued at $219,000 after purchasing an additional 408 shares during the period. Pinnacle Holdings LLC boosted its stake in shares of Yelp by 1.2% during the third quarter. Pinnacle Holdings LLC now owns 35,838 shares of the local business review company’s stock valued at $1,118,000 after purchasing an additional 413 shares during the period. CWA Asset Management Group LLC boosted its stake in shares of Yelp by 2.2% during the fourth quarter. CWA Asset Management Group LLC now owns 19,871 shares of the local business review company’s stock valued at $604,000 after purchasing an additional 436 shares during the period. Finally, Bfsg LLC boosted its stake in shares of Yelp by 110.3% during the third quarter. Bfsg LLC now owns 839 shares of the local business review company’s stock valued at $26,000 after purchasing an additional 440 shares during the period. Hedge funds and other institutional investors own 90.11% of the company’s stock.

About Yelp (Get Free Report)

Yelp is a digital platform that connects consumers with local businesses through user-generated reviews, ratings and multimedia content. The company’s flagship offerings include the Yelp website and mobile applications for iOS and Android, where users can search for and discover restaurants, shops, service providers and other points of interest. In addition to crowd-sourced reviews and photographs, Yelp provides business profile pages featuring hours, contact information, menus and direct messaging capabilities.

Yelp generates revenue primarily through advertising services sold to small and medium-sized enterprises.

Featured Articles Five stocks we like better than Yelp

Receive News & Ratings for Yelp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yelp and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of Stockton Buys 2,068 Shares of Amazon.com, Inc. $AMZN

NEXT HEADLINE »Brazilian Electric Power (NYSE:AXIA) Insider Sells $189,750.00 in Stock

The new AI-powered Yelp Assistant works across every category on Yelp and helps consumers book, order and schedule in one conversation

New integrations with Vagaro, Zocdoc and Calendly expand seamless booking across Yelp

Enhanced Menu Vision overlays dish photos on menus using a phone camera

SAN FRANCISCO--(BUSINESS WIRE)--Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced its Spring Product Release, introducing more than 35 new features and updates that transform how consumers discover, connect and get things done with local businesses. The release unveils the new Yelp Assistant, an AI-powered chatbot that delivers instant answers, reliable recommendations and seamless booking—from restaurant reservations to beauty appointments—all in one conversation. New integrations with Vagaro, Zocdoc and Calendly expand scheduling capabilities across more categories on Yelp, while enhancements to AI-powered Menu Vision make deciding what to order more visual and engaging. The release also introduces new tools for advertisers, including an AI-powered support chatbot and enhanced advertising tools.

Yelp's 2026 Spring Product Release introduces 35+ new features and updates, including the new Yelp Assistant, expanded booking integrations, and an enhanced Menu Vision.

Share “The new Yelp Assistant is our most significant AI product evolution yet as we reconceive Yelp around instant answers and seamless actions,” said Craig Saldanha, chief product officer at Yelp. “The experiences and opinions from real people that power every recommendation are what sets Yelp Assistant apart, delivering trustworthy results that help consumers make confident decisions, faster. And for the first time, consumers can seamlessly move from discovery to action in a single conversation with new and enhanced integrations—from booking a table, to ordering delivery or scheduling an appointment. As we transform Yelp with AI, this is only the beginning of a more conversational, personalized and action-oriented Yelp experience.”

Discover and get things done across every category with AI-powered Yelp Assistant

First introduced to help consumers hire services professionals and answer questions about individual businesses, Yelp Assistant now works across every category on Yelp and is accessible at the center of the app through a new “Assistant” tab on iOS and Android. Powered by hundreds of millions of reviews, photos and detailed business information from the Yelp community, Yelp Assistant can handle complex and highly specific requests and surfaces real user-generated content from first-hand experiences in answers to validate each recommendation.

New and existing integrations make it easy to go from discovery to doing, directly from the app:

Reserve a table at thousands of restaurants that use Yelp Guest Manager for table booking, with the ability to join a Yelp Waitlist coming soon. Order takeout or delivery from more than half a million restaurants through DoorDash, Yelp’s preferred partner, as well as Grubhub and other food delivery platforms. Request a quote from professionals across more than 450 categories, including home, local, auto, beauty, pet and event services. Book appointments through integrations with Vagaro on iOS for beauty, wellness and fitness businesses, Zocdoc on iOS for healthcare providers, RepairPal for auto shops and, later this summer, Calendly for service professionals. More ways to book, order and schedule on Yelp

The new integrations available through Yelp Assistant are now also accessible throughout the Yelp app, making it easier than ever for consumers to take action across the platform. New partnerships with Vagaro, Zocdoc and Calendly bring booking, ordering and scheduling capabilities to more categories.

Vagaro: Consumers can now book beauty and wellness appointments—such as haircuts, massages and nail services—on Yelp through a new integration with Vagaro, a leading salon, spa and fitness marketplace. Available on iOS, the Vagaro integration will be available on Android and desktop later this year. Zocdoc: For the first time, consumers can go from finding to booking a doctor on Yelp through a new integration with Zocdoc, the healthcare access platform that connects patients to great care. Available on iOS, the Zocdoc integration will be coming to Android and desktop later this year. Calendly: Service professionals can now connect their Calendly schedules to Yelp, allowing consumers to book consultations and appointments seamlessly. “Through our expanded integration with Yelp, we’re making it easier than ever for consumers to move from discovery to booking in just a few taps,” said Fred Helou, CEO of Vagaro. “By connecting Yelp’s powerful search and recommendation platform with Vagaro’s robust scheduling capabilities, beauty, wellness and fitness businesses can capture high-intent customers at the exact moment they’re ready to book. We’re excited to partner with Yelp to deliver a more seamless, end-to-end experience that benefits both businesses and their clients.”

“Booking a doctor’s appointment should be just as easy as booking dinner,” said Oliver Kharraz, MD, founder and CEO of Zocdoc. “Integrating Zocdoc’s healthcare access infrastructure into Yelp is another step toward making access to in-network care simple and immediate, wherever patients begin their search.”

"Scheduling should be the easiest part of winning a new customer,” said Chirag Chheda, CTO of Calendly. “Our integration with Yelp makes that a reality for service professionals by bringing Calendly's real-time availability directly into the conversation when a customer is ready to book. This partnership represents a deeper expansion into home services, connecting our scheduling platform with one of the largest marketplaces where high intent consumers discover and connect with businesses every day. We're excited to help service pros on Yelp turn more leads into appointments with less effort."

Smarter menus, personalized feeds and more

Additional features and updates from Yelp’s 2026 Spring Product Release:

Enhanced Menu Vision: First introduced in 2025, Menu Vision now overlays photos of dishes, drinks and desserts directly over text-based menus when viewed through diners’ phone cameras. “Popular” badges call out standout items, and with one tap, consumers can read reviews about the item. Plus, expanded coverage and improved matching accuracy mean more items are recognized across more restaurants. Menu Vision is available on iOS and Android from a business’s media gallery or directly from the business page under the menu section. A more personalized and engaging home feed: A new AI-powered personalization model for the Yelp home feed on iOS surfaces more relevant, tailored content, more updates from people you follow, immersive full-screen videos and smarter nearby recommendations. Smarter photo discovery: Natural language search within a business’s media gallery allows consumers to use conversational queries to find specific photos. AI-powered chat support: Yelp’s new AI-powered support chatbot for advertisers helps business owners get answers and resolve issues faster. Built with advanced large language models, the chatbot delivers conversational assistance across a wide range of support topics and provides intelligent real-time solutions. Yelp is also rolling out new tools to help businesses manage leads and optimize their advertising. Additional information and assets

For more details on the news, learn more in Yelp’s 2026 Spring Product Release blog post, and a Q&A with Yelp's Vice President of Product Nicole Lund on what's next for local businesses on Yelp. Assets and images are available here. For further information about Yelp, visit the company’s Fast Facts page.

About Yelp Inc.

Yelp Inc. (yelp.com) is a community-driven platform that connects people with great local businesses. Millions of people rely on Yelp for useful and trusted local business information, reviews, and photos to help inform their spending decisions. As a one-stop local platform, Yelp helps consumers easily discover, connect, and transact with businesses across a broad range of categories by making it easy to request a quote for a service, book a table at a restaurant, and more. Yelp was founded in San Francisco in 2004.

Forward-looking statements

This press release contains forward-looking statements relating to, among other things, Yelp’s future product plans, including the ability of its investments and initiatives to drive profitable long-term growth and shareholder value, which are based on its current expectations, forecasts, and assumptions that involve risks and uncertainties.

Factors that could cause or contribute to such differences also include, but are not limited to, those factors that could affect Yelp’s business, operating results, and stock price included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Yelp’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q at yelp-ir.com or the SEC’s website at sec.gov.

More News From Yelp Inc.

SAN FRANCISCO--(BUSINESS WIRE)--Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced that it will release its financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 7, 2026.

Yelp will issue a press release when its Shareholder Letter has been posted on its investor relations website at www.yelp-ir.com. Following the release of the Shareholder Letter, Yelp will host a webcasted conference call to discuss its first quarter results starting at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. The live and archived webcasts will be accessible from Yelp’s investor relations website at the same web address as above.

About Yelp

Yelp Inc. (yelp.com) is a community-driven platform that connects people with great local businesses. Millions of people rely on Yelp for useful and trusted local business information, reviews and photos to help inform their spending decisions. As a one-stop local platform, Yelp helps consumers easily discover, connect and transact with businesses across a broad range of categories by making it easy to request a quote for a service, book a table at a restaurant, and more. Yelp was founded in San Francisco in 2004.

More News From Yelp Inc.

Posted by Defense World Staff on Apr 27th, 2026

Shares of Yelp Inc. (NYSE:YELP – Get Free Report) have earned a consensus recommendation of “Reduce” from the eight brokerages that are currently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $28.50.

Several equities analysts have recently commented on YELP shares. Robert W. Baird set a $25.00 price target on shares of Yelp in a research report on Friday, February 13th. Morgan Stanley reduced their price target on shares of Yelp from $30.00 to $28.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 13th. JPMorgan Chase & Co. cut their target price on shares of Yelp from $30.00 to $22.00 and set a “neutral” rating on the stock in a report on Tuesday, February 17th. Wall Street Zen downgraded Yelp from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, Weiss Ratings downgraded Yelp from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, February 11th.

Check Out Our Latest Research Report on Yelp

Yelp Stock Performance Shares of YELP stock opened at $28.75 on Monday. Yelp has a one year low of $19.60 and a one year high of $41.22. The company’s 50-day simple moving average is $24.49 and its 200-day simple moving average is $27.79. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of 12.78, a PEG ratio of 0.72 and a beta of 0.47.

Yelp (NYSE:YELP – Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The local business review company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.47 by $0.14. Yelp had a net margin of 9.94% and a return on equity of 19.96%. The business had revenue of $359.99 million for the quarter, compared to analysts’ expectations of $358.70 million. During the same quarter last year, the company posted $0.62 earnings per share. The company’s quarterly revenue was down .5% compared to the same quarter last year. As a group, research analysts forecast that Yelp will post 2.02 EPS for the current year.

Insider Buying and Selling In other Yelp news, Director Dan Jedda sold 1,464 shares of Yelp stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $21.02, for a total value of $30,773.28. Following the completion of the transaction, the director directly owned 17,100 shares in the company, valued at $359,442. The trade was a 7.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO David A. Schwarzbach sold 10,000 shares of Yelp stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the transaction, the chief financial officer owned 227,959 shares of the company’s stock, valued at approximately $5,698,975. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 156,264 shares of company stock valued at $4,115,893. 7.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Yelp A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. LSV Asset Management boosted its stake in Yelp by 11.6% in the fourth quarter. LSV Asset Management now owns 2,682,238 shares of the local business review company’s stock valued at $81,513,000 after acquiring an additional 279,300 shares during the period. Dimensional Fund Advisors LP boosted its stake in Yelp by 7.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,226,666 shares of the local business review company’s stock valued at $67,666,000 after acquiring an additional 156,430 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in shares of Yelp by 8.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,976,150 shares of the local business review company’s stock valued at $61,656,000 after buying an additional 151,354 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Yelp by 7.0% during the second quarter. Ameriprise Financial Inc. now owns 1,501,764 shares of the local business review company’s stock valued at $51,458,000 after buying an additional 98,303 shares during the last quarter. Finally, River Road Asset Management LLC raised its holdings in shares of Yelp by 1.4% during the fourth quarter. River Road Asset Management LLC now owns 1,161,711 shares of the local business review company’s stock valued at $35,304,000 after buying an additional 15,849 shares during the last quarter. 90.11% of the stock is currently owned by institutional investors and hedge funds.

About Yelp (Get Free Report)

Yelp is a digital platform that connects consumers with local businesses through user-generated reviews, ratings and multimedia content. The company’s flagship offerings include the Yelp website and mobile applications for iOS and Android, where users can search for and discover restaurants, shops, service providers and other points of interest. In addition to crowd-sourced reviews and photographs, Yelp provides business profile pages featuring hours, contact information, menus and direct messaging capabilities.

Yelp generates revenue primarily through advertising services sold to small and medium-sized enterprises.

Recommended Stories Five stocks we like better than Yelp

Receive News & Ratings for Yelp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yelp and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEGambling.com Group Limited (NASDAQ:GAMB) Receives Average Rating of “Moderate Buy” from Analysts

NEXT HEADLINE »Medalist Diversified REIT (NASDAQ:MDRR) & Clipper Realty (NYSE:CLPR) Critical Analysis

Analysts on Wall Street project that Yelp (YELP - Free Report) will announce quarterly earnings of $0.26 per share in its forthcoming report, representing a decline of 27.8% year over year. Revenues are projected to reach $354.57 million, declining 1.1% from the same quarter last year.

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Given this perspective, it's time to examine the average forecasts of specific Yelp metrics that are routinely monitored and predicted by Wall Street analysts.

Based on the collective assessment of analysts, 'Net revenue- Advertising' should arrive at $332.17 million. The estimate indicates a year-over-year change of -2.9%.

It is projected by analysts that the 'Net revenue- Other services' will reach $22.40 million. The estimate points to a change of +35.5% from the year-ago quarter.

Analysts' assessment points toward 'Net revenue- Advertising revenue- Services' reaching $233.42 million. The estimate points to a change of +0.8% from the year-ago quarter.

Analysts forecast 'Net revenue- Advertising revenue- Restaurants, Retail & Other' to reach $100.13 million. The estimate points to a change of -9.3% from the year-ago quarter.

The combined assessment of analysts suggests that 'Paying Advertising Locations' will likely reach 492.50 thousand. The estimate is in contrast to the year-ago figure of 517.00 thousand.

The average prediction of analysts places 'Paying Advertising Locations - Restaurants, Retail & Other' at 236.08 thousand. Compared to the current estimate, the company reported 256.00 thousand in the same quarter of the previous year.

The consensus among analysts is that 'Paying Advertising Locations - Services' will reach 256.42 thousand. The estimate is in contrast to the year-ago figure of 261.00 thousand.

View all Key Company Metrics for Yelp here>>>

Over the past month, shares of Yelp have returned +14.2% versus the Zacks S&P 500 composite's +10.3% change. Currently, YELP carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Yelp (YELP - Free Report) reported $361.46 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 0.8%. EPS of $0.36 for the same period compares to $0.36 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $354.57 million, representing a surprise of +1.94%. The company delivered an EPS surprise of +38.46%, with the consensus EPS estimate being $0.26.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Yelp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Paying Advertising Locations: 485 thousand versus 492.5 thousand estimated by three analysts on average.Paying Advertising Locations - Restaurants, Retail & Other: 235 thousand compared to the 236.08 thousand average estimate based on three analysts.Paying Advertising Locations - Services: 250 thousand versus 256.42 thousand estimated by three analysts on average.Net revenue- Advertising: $332.49 million versus $332.17 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -2.8% change.Net revenue- Other services: $28.97 million versus $22.4 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +75.2% change.Net revenue- Advertising revenue- Services: $233.79 million versus the three-analyst average estimate of $233.42 million. The reported number represents a year-over-year change of +1%.Net revenue- Advertising revenue- Restaurants, Retail & Other: $98.7 million compared to the $100.13 million average estimate based on three analysts. The reported number represents a change of -10.6% year over year.View all Key Company Metrics for Yelp here>>>

Shares of Yelp have returned +11.5% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.